Dermatology
Conference Coverage
Atopic dermatitis, sleep difficulties often intertwined
For the management of insomnia, try behavioral approaches first.
Conference Coverage
What drives treatment satisfaction among adults with atopic dermatitis?
Adults with AD and lower income, no health insurance, and multimorbidity had even lower treatment satisfaction.
Conference Coverage
Severe atopic dermatitis often puts a dent in quality of life
“There have been many surveys of adults with AD who report impairment of their sleep, reduced activity level, increased work absence, financial...
From the Journals
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquine
Four medical societies issued a joint statement on the low risk of retinopathy and risk factor management.
Conference Coverage
Data on atopic dermatitis risk factors are accumulating
“The list of culprits is ever increasing,” Dr. Zelma Chiesa Fuxench said.
From the Journals
AI detects ugly-duckling skin lesions for melanoma follow-up
Using wide-field photos, a new artificial intelligence program can pick out lesions worthy of follow up for potential melanoma.
From the Journals
Methotrexate-associated hepatotoxicity risk differs between psoriasis, PsA, and RA patients
When results were adjusted with Cox regression analyses, the psoriasis group had a significantly increased risk compared with the RA group with...
Conference Coverage
Emerging treatments for molluscum contagiosum and acne show promise
"The treatment of molluscum is still an unmet need," Dr. Kircik said.
Myth of the Month
Cellulitis treatment recommendations
Which type of antibiotic would provide the best coverage and lowest minimal inhibitory concentration for the likely organism?
Conference Coverage
Pandemic puts patients with psoriatic disease off seeking medical help
Both the physical and mental health of people with psoriasis and psoriatic arthritis has been affected by the ongoing COVID-19 pandemic.
From the Journals
Less pain, same gain with tirbanibulin for actinic keratosis
The results, assessed at day 57 and out to 1 year of follow-up, were associated with recurrence of lesions at 1 year.